Results 111 to 120 of about 7,182,421 (220)

Dattabase Information from Structure-based design of an urokinase-type plasminogen activator receptor–derived peptide inhibiting cell migration and lung metastasis

, 2009
Dattabase Information from Structure-based design of an urokinase-type plasminogen activator receptor–derived peptide inhibiting cell migration and lung ...
Mario De Rosa (15040481), Liliana Lista (2709868), Giuseppina Votta (2141533), Maria Vincenza Carriero (8713431), Renato Franco (184143), Maria Teresa Masucci (15040478), Maria Patrizia Stoppelli (133653), Katia Bifulco (133627), Vincenzo Pavone (133641), Claudio Arra (133331), Antonio Barbieri (458558), Immacolata Longanesi-Cattani (133632), Ornella Maglio (4379920)   +12 more
core   +1 more source

Role of Soluble Urokinase-Type Plasminogen Activator Receptor in Cardiovascular Disease. [PDF]

Curr Cardiol Rep, 2023
Ismail A, Hayek SS.
europepmc   +1 more source

Prognostic value of urokinase plasminogen activator for prostatic carcinoma.

, 1994
The usefulness of routine clinical application of the urokinase plasminogen activator in prostate cancer was evaluated. The urokinase values of prostate cancer confined to the organ, with extraprostatic spread and with metastatic disease did not differ ...
Plas E, Lehmann K, Hauri D, Gautschi K
core   +1 more source

The autoactivation of human single-chain urokinase-type plasminogen activator (uPA). [PDF]

J Biol Chem, 2023
Torres-Paris C, Chen Y, Xiao L, Song HJ, Chen P, Komives EA.   +5 more
europepmc   +1 more source

Urokinase-type Plasminogen Activator-induced Mouse Back Pain Model. [PDF]

J Vis Exp, 2023
Montera MA, Goins AE, Alles SRA, Westlund KN.   +3 more
europepmc   +1 more source

Urokinase-Type Plasminogen Activator [PDF]

, 2020
openaire   +1 more source

Urokinase-type plasminogen activator (uPA) regulates invasion and matrix remodelling in colorectal cancer. [PDF]

Matrix Biol Plus, 2023
Micalet A, Tappouni LJ, Peszko K, Karagianni D, Lam A, Counsell JR, Quezada SA, Moeendarbary E, Cheema U.   +8 more
europepmc   +1 more source

Urokinase -type Plasminogen Activator System in Human Breast Cancer [PDF]

, 2013
Urokinase plasminogen activator (uPA), urokinase plasminogen activator receptor (uPAR) and plasminogen activator inhibitor-1(PAI-1) are essential for metastasis, and overexpression of these molecules is strongly correlated with poor prognosis in a ...
Al-Rawi, Ali Hussien Al-Khafaji, Al-Jubouri, Aftan Faeza, Salim Reyadh   +4 more
core  

Vectors and methods for recombinant production of uPA-binding fragments of the human urokinase-type plasminogen receptor (uPAR)

, 1999
Activation of plasminogen to plasma is inhibited by preventing the binding of a receptor binding form of urokinase-type plasminogen activator to a urokinase-type plasminogen activator receptor in a mammal, thereby preventing the urokinase-type ...
Pollanen,, Jari, Vaheri,, Antti, Lund, Leif, Roege, Pyke, Charles, Masucci, Maria, Teresa, Roldan, Ann, Louring, Cubellis, Maria, Vittoria, Tapiovaara,, Hannele, Ellis,, Vincent, Rønne, Ebbe, Patthy, Laszlo, Salonen,, Eeva-Marjatta, Ploug,, Michael, Stephens, Ross, W, Blasi, Francesco, Appella,, Ettore, Schleuning,, Wolf-Dieter, Danoe,, Keld, Behrendt,, Niels, Kristensen,, Peter, Moeller, Lisbeth Birk   +20 more
core  

Urokinase-Type Plasminogen Activator Receptor Regulates Prosurvival and Angiogenic Properties of Cardiac Mesenchymal Stromal Cells. [PDF]

Int J Mol Sci, 2023
Dergilev K, Tsokolaeva Z, Goltseva Y, Beloglazova I, Ratner E, Parfyonova Y.   +5 more
europepmc   +1 more source